Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CR.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BV.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BV.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.4.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.4.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.4.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.7.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GS.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.7.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XWORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XWENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XWNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDJORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDJENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDJNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used